Table 2.
Clinical Interpretation of Key CBC Parameters.
| Parameter | What it reflects | Key clinical interpretation | Practical clinical implications |
|---|---|---|---|
| Hemoglobin (Hb) | Oxygen-carrying capacity | Presence and severity of anemia or erythrocytosis | Assess the need for urgent evaluation or transfusion according to severity, symptoms, and clinical context |
| RBC count | Number of circulating erythrocytes | Helps distinguish true anemia or erythrocytosis from dilutional or relative changes | Interpret together with Hb, hematocrit, and plasma volume status |
| MCV | Average red blood cell size | Classifies anemia as microcytic, normocytic, or macrocytic | Interpret with RDW and clinical context; should not be used in isolation |
| MCHC | Hemoglobin concentration in RBCs | Reflects hemoglobinization | Low values suggest iron deficiency or hypochromia; high values may suggest spherocytosis or analytical artifact |
| RDW | Variability in RBC size (anisocytosis) | Detects mixed RBC populations and dynamic erythropoiesis | May provide an early clue to deficiency states, mixed anemia, or recovery after treatment |
| Reticulocyte count (absolute) | Bone marrow erythropoietic response | Distinguishes increased marrow response from impaired production | Approximately >80,000/μL suggests increased erythropoietic response; approximately <20,000/μL suggests markedly impaired erythropoiesis |
| WBC count | Total leukocyte number | Indicates inflammation, infection, stress response, or marrow disorder | Interpret with differential count, analyzer flags, and clinical context |
| Absolute neutrophil count (ANC) | Neutrophil-mediated host defense | Best indicator of infection risk related to neutropenia | Severe neutropenia is associated with high infection risk |
| Platelet count (PLT) | Number of circulating platelets | Reflects bleeding or thrombotic tendency | Must be interpreted with clinical context and possible artifacts such as platelet clumping |
| MPV | Platelet size | Suggests platelet production dynamics | Limited by pre-analytical and analyzer-related variability; interpret cautiously |
| IPF* | Immature platelet fraction | Reflects bone marrow thrombopoietic activity | Increased IPF suggests peripheral platelet destruction or recovery of thrombopoiesis; markedly increased IPF may suggest inherited macrothrombocytopenia such as MYH9-related disease; increased IPF despite PLT ≥50 × 109/L may support consideration of MDS |
ANC: absolute neutrophil count; CBC: complete blood count; Hb: hemoglobin; IPF: immature platelet fraction; MCHC: mean corpuscular hemoglobin concentration; MCV: mean corpuscular volume; MDS: myelodysplastic syndromes; MPV: mean platelet volume; PLT: platelet count; RBC: red blood cell; RDW: red cell distribution width; WBC: white blood cell.
*Availability and reporting of IPF vary among analyzers and institutions.